Skip to main content
logo
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
27.01
+0.36 (1.35%)
At close: Aug 6, 2026, 4:00 PM EDT
26.94
-0.07 (-0.26%)
After-hours: Aug 6, 2026, 7:34 PM EDT

Cue Biopharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
32.7327.479.295.491.2514.94
Revenue Growth
309.60%195.75%69.16%340.96%-91.67%373.68%
Gross Profit
32.7327.479.295.491.2514.94
Operating Income
-19.61-26.55-41.5-52.15-53.23-43.71
Net Income
-19.52-26.6-40.67-50.73-53.01-44.16
Earnings Per Share
-5.58-8.40-21.60-33.30-44.70-42.30
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
16.3827.1422.4648.5176.2964.37
Total Debt
3.444.28.8814.719.3210.05
Net Cash (Debt)
12.9422.9413.5833.8256.9754.32
Net Cash Growth
115.25%68.88%-59.84%-40.64%4.89%-30.11%
Net Cash Per Share
3.447.267.2322.1747.9552.09

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-24.46-21.69-36.33-39.96-41.81-38.84
Capital Expenditures
-0.15-0.18-0.07--0.17-0.91
Free Cash Flow
-24.61-21.86-36.4-39.96-41.98-39.75
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-59.90%-96.67%-446.86%-949.89%-4275.10%-292.56%
Pretax Margin
-58.12%-95.03%-437.97%-924.10%-4257.83%-292.25%
Profit Margin
-58.12%-96.85%-437.97%-924.10%-4257.83%-295.56%
FCF Margin
-75.17%-79.60%-391.89%-727.89%-3371.65%-266.04%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
3.471.077.2622.7098.5324.38